Newcastle University
Scientific title
Development and clinical trial feasibility evaluation of auditory rhythmical cueing to improve gait and physical activity in community dwelling stroke survivors.
Principal Investigator
Dr Sarah Moore
Year awarded
Grant value
Research ID
TSA 2016-06
Research area
Start date
Saturday 1 July 2017
End date
Wednesday 1 July 2020
3 years


This research project is about improving walking after stroke which is often a problem. As well as reducing independence, walking problems lead to lower daily activity increasing risk of further stroke and health problems.

A promising method of improving walking after stroke is through ‘auditory rhythmical cueing.’

‘Auditory rhythmical cueing’ involves people walking to the rhythm of a sound beat. This method improves walking after stroke in the hospital, but has not been tested later on at home where recovery could continue.

Study aim

To determine whether it is possible for people with stroke to safely take part in an ‘auditory rhythmical cueing’ walking programme in the community.

Project plan

Year one will be spent listening to the views of people with stroke, carers and health professionals on the best ways to deliver ‘auditory rhythmical cueing’. We will develop training materials and test the best method of delivering ‘auditory rhythmical cueing’ in the community with a small group of patients.

A two year study will then test if we can deliver ‘auditory rhythmical cueing’ in four different North East stroke services. The study will recruit 60 participants.

Patient involvement

The views of people with stroke were sought and taken on board when developing this project. There is a stroke survivor on the study team to help guide the project.

Sharing results

Results will be shared with people who took part at an open evening. Results will also be shared with people working in stroke care and people doing research at meetings and through journal articles. 

Long term goal

To test whether ‘auditory rhythmical cueing’ improves walking and is good value for money in a large scale study.